Success Story: Molecular Biology Researcher Secures I-140 NIW Approval in Just 33 Days through Premium Processing
Client’s Testimonial:
"Thank you very much for all the work you have done. It was a pleasure working with you. I will recommend your services to my friends and colleagues.”
On April 29th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Associate in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: Postdoctoral Associate
Country of Origin: Russia
State of Residence at the Time of Filing: New York
Approval Notice Date: April 29th, 2026
Processing Time: 1 month, 2 days (Premium Processing Requested)
Case Summary:
We are pleased to share that the client, an expert in molecular biology, received I-140 NIW approval in just 33 days through direct Premium Processing at the time of filing. The client’s proposed endeavor focused on identifying the molecular mechanisms underlying interactions between pioneer transcription factors and DNA during embryogenesis, with the broader goal of advancing fundamental biological discovery and supporting future medical applications.
The client is currently conducting research in a U.S.-based academic setting and intends to continue work involving gene transcriptional activity, embryonic development, and molecular processes that may inform future approaches in regenerative medicine, developmental biology, and disease-related research. In the petition, we demonstrated that this work carried substantial merit and national importance by connecting the client’s research to broader needs in understanding developmental disorders, neurodegenerative disease mechanisms, and emerging biotechnology areas.
To show that the client was well-positioned to advance the proposed endeavor, we emphasized a record of peer-reviewed scholarship and independent reliance by other researchers. The client authored 7 peer-reviewed journal articles, including 1 first-authored article, and the published body of work had received 146 citations. Rather than presenting these numbers alone, the petition explained how citation activity reflected use of the client’s findings by other scientists studying gene regulation, reproductive biology, neuronal function, and embryonic development. We also highlighted that one article ranked among the top 10% most-cited articles in its field and year, strengthening the argument that the client’s work had influenced the broader molecular biology community.
The petition further documented the client’s major funding connection through the National Institutes of Health. This evidence helped show that the research aligned with recognized U.S. priorities in advancing biological knowledge, reducing illness and disability, and supporting scientific innovation with potential public health value.
Expert support also played an important role. We included 2 recommendation letters from specialists familiar with the client’s achievements and the significance of the work. These letters supported the argument that the client’s research record, technical expertise, and continued work in molecular biology positioned the client to contribute meaningfully to the United States.
“It is beyond doubt that [Client] shall continue to pioneer even more valuable research, contributing immensely to the field while benefiting national and international concerns in reproductive health and medicine.”
With a carefully prepared petition, North America Immigration Law Group showed that the client’s work was not limited to routine academic output but reflected a focused and nationally relevant research trajectory. We congratulate the client on this swift I-140 NIW approval and wish the client continued success in advancing molecular biology research with meaningful implications for medicine and public health.